Literature DB >> 18205192

The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation.

Sheron Perera1, Bharati Bapat.   

Abstract

Germline mutations in the mismatch repair genes lead to the Lynch syndrome/ HNPCC, and genetic testing is offered to identify individuals at risk of developing this disease. About a third of all genetic alterations detected in the mismatch repair gene MutL homolog 1 (MLH1) are missense variants. The majority of these variants are of equivocal clinical significance. In this report, we investigate the molecular basis of the pathogenicity of three missense variants localized to distinct functional domains. Our results demonstrate that the MLH1 variants p.Arg265Cys (c.793C>T) and p.Lys618Ala (c.1852_1853AA>GC) significantly decrease the stability of the protein, while another missense variant p.Leu749Gln (c.2246T>A) is able to compromise heterodimerization of the MLH1-PMS2 complex. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205192     DOI: 10.1002/humu.9523

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  18 in total

Review 1.  Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer.

Authors:  Christopher D Heinen
Journal:  DNA Repair (Amst)       Date:  2015-12-02

2.  Full-length transcript amplification and sequencing as universal method to test mRNA integrity and biallelic expression in mismatch repair genes.

Authors:  Monika Morak; Kerstin Schaefer; Verena Steinke-Lange; Udo Koehler; Susanne Keinath; Trisari Massdorf; Brigitte Mauracher; Nils Rahner; Jessica Bailey; Christiane Kling; Tanja Haeusser; Andreas Laner; Elke Holinski-Feder
Journal:  Eur J Hum Genet       Date:  2019-07-22       Impact factor: 4.246

3.  Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods.

Authors:  Sanjeevani Arora; Peter J Huwe; Rahmat Sikder; Manali Shah; Amanda J Browne; Randy Lesh; Emmanuelle Nicolas; Sanat Deshpande; Michael J Hall; Roland L Dunbrack; Erica A Golemis
Journal:  Cancer Biol Ther       Date:  2017-05-11       Impact factor: 4.742

4.  The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors.

Authors:  Fabiola Medeiros; Noralane M Lindor; Fergus J Couch; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2012-03-13       Impact factor: 5.568

5.  A novel and rapid method of determining the effect of unclassified MLH1 genetic variants on differential allelic expression.

Authors:  Sheron Perera; Brian Li; Soultana Tsitsikotas; Lily Ramyar; Aaron Pollett; Kara Semotiuk; Bharati Bapat
Journal:  J Mol Diagn       Date:  2010-09-23       Impact factor: 5.568

6.  Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report.

Authors:  Matjaz Vogelsang; Radovan Komel
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

7.  The C-terminal domain of the MutL homolog from Neisseria gonorrhoeae forms an inverted homodimer.

Authors:  Sivakumar Namadurai; Deepti Jain; Dhananjay S Kulkarni; Chaitanya R Tabib; Peter Friedhoff; Desirazu N Rao; Deepak T Nair
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

8.  A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations.

Authors:  Cristina Martínez-Bouzas; Elena Beristain; Enrique Ojembarrena; Jose Errasti; Karmele Mujika; Noelia Viguera; Maria Isabel Tejada
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

9.  A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.

Authors:  Bryony A Thompson; David E Goldgar; Carol Paterson; Mark Clendenning; Rhiannon Walters; Sven Arnold; Michael T Parsons; Walsh Michael D; Steven Gallinger; Robert W Haile; John L Hopper; Mark A Jenkins; Loic Lemarchand; Noralane M Lindor; Polly A Newcomb; Stephen N Thibodeau; Joanne P Young; Daniel D Buchanan; Sean V Tavtigian; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

10.  Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.

Authors:  S Gargiulo; M Torrini; S Ollila; S Nasti; L Pastorino; R Cusano; L Bonelli; L Battistuzzi; L Mastracci; W Bruno; V Savarino; S Sciallero; G Borgonovo; M Nyström; G Bianchi-Scarrà; C Mareni; P Ghiorzo
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.